HOLLY POWDERLY: Open Payments
NPI 1619209053 · CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 10 payments from 8 companies in 2025. Trend: 2023 $511 · 2024 $117 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Lundbeck LLC | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: Kerendia, REXULTI, TRELEGY ELLIPTA, THINPREP 2000 PROCESSOR, Rybelsus, JARDIANCE, PREVNAR 20, XIFAXAN.
Industry payments across MA — which companies pay providers there.
